Structural basis of ribosomal peptide macrocyclization in plants

  1. Joel Haywood
  2. Jason W Schmidberger
  3. Amy M James
  4. Samuel G Nonis
  5. Kirill V Sukhoverkov
  6. Mikael Elias
  7. Charles S Bond
  8. Joshua S Mylne  Is a corresponding author
  1. The University of Western Australia, Australia
  2. University of Minnesota, United States

Abstract

Constrained, cyclic peptides encoded by plant genes represent a new generation of drug leads. Evolution has repeatedly recruited the Cys-protease asparaginyl endopeptidase (AEP) to perform their head-to-tail ligation. These macrocyclization reactions use the substrates amino terminus instead of water to deacylate, so a peptide bond is formed. How solvent-exposed plant AEPs macrocyclize is poorly understood. Here we present the crystal structure of an active plant AEP from the common sunflower, Helianthus annuus. The active site contained electron density for a tetrahedral intermediate with partial occupancy that predicted a binding mode for peptide macrocyclization. By substituting catalytic residues we could alter the ratio of cyclic to acyclic products. Moreover, we showed AEPs from other species lacking cyclic peptides can perform macrocyclization under favorable pH conditions. This structural characterization of AEP presents a logical framework for engineering superior enzymes that generate macrocyclic peptide drug leads.

Data availability

The following data sets were generated

Article and author information

Author details

  1. Joel Haywood

    School of Molecular Sciences, The University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  2. Jason W Schmidberger

    School of Molecular Sciences, The University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  3. Amy M James

    School of Molecular Sciences, The University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  4. Samuel G Nonis

    School of Molecular Sciences, The University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  5. Kirill V Sukhoverkov

    School of Molecular Sciences, The University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  6. Mikael Elias

    Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, St Paul, United States
    Competing interests
    The authors declare that no competing interests exist.
  7. Charles S Bond

    School of Molecular Sciences, The University of Western Australia, Perth, Australia
    Competing interests
    The authors declare that no competing interests exist.
  8. Joshua S Mylne

    School of Molecular Sciences, The University of Western Australia, Perth, Australia
    For correspondence
    joshua.mylne@uwa.edu.au
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4957-6388

Funding

Australian Research Council (FT120100013)

  • Joshua S Mylne

Australian Research Council (DP160100107)

  • Joshua S Mylne

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Charles S Craik, University of California, San Francisco, United States

Publication history

  1. Received: October 19, 2017
  2. Accepted: January 26, 2018
  3. Accepted Manuscript published: January 31, 2018 (version 1)
  4. Version of Record published: March 2, 2018 (version 2)

Copyright

© 2018, Haywood et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,906
    Page views
  • 474
    Downloads
  • 35
    Citations

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Joel Haywood
  2. Jason W Schmidberger
  3. Amy M James
  4. Samuel G Nonis
  5. Kirill V Sukhoverkov
  6. Mikael Elias
  7. Charles S Bond
  8. Joshua S Mylne
(2018)
Structural basis of ribosomal peptide macrocyclization in plants
eLife 7:e32955.
https://doi.org/10.7554/eLife.32955

Further reading

    1. Structural Biology and Molecular Biophysics
    Amy Osterman, Alfonso Mondragón
    Research Article

    Topoisomerase V is a unique topoisomerase that combines DNA repair and topoisomerase activities. The enzyme has an unusual arrangement, with a small topoisomerase domain followed by 12 tandem (HhH)2 domains, which include three AP lyase repair domains. The uncommon architecture of this enzyme bears no resemblance to any other known topoisomerase. Here we present structures of topoisomerase V in complex with DNA. The structures show that the (HhH)2 domains wrap around the DNA and in this manner appear to act as a processivity factor. There is a conformational change in the protein to expose the topoisomerase active site. The DNA bends sharply to enter the active site, which melts the DNA and probably facilitates relaxation. The structures show a DNA binding mode not observed before and provide information on the way this atypical topoisomerase relaxes DNA. In common with type IB enzymes, topoisomerase V relaxes DNA using a controlled rotation mechanism, but the structures show that topoisomerase V accomplishes this in different manner. Overall, the structures firmly establish that type IC topoisomerases form a distinct type of topoisomerases, with no similarities to other types at the sequence, structural, or mechanistic level. They represent a completely different solution to DNA relaxation.

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Sarah R Hansen et al.
    Research Article

    In eukaryotes, splice sites define the introns of pre-mRNAs and must be recognized and excised with nucleotide precision by the spliceosome to make the correct mRNA product. In one of the earliest steps of spliceosome assembly, the U1 small nuclear ribonucleoprotein (snRNP) recognizes the 5' splice site (5' SS) through a combination of base pairing, protein-RNA contacts, and interactions with other splicing factors. Previous studies investigating the mechanisms of 5' SS recognition have largely been done in vivo or in cellular extracts where the U1/5' SS interaction is difficult to deconvolute from the effects of trans-acting factors or RNA structure. In this work we used co-localization single-molecule spectroscopy (CoSMoS) to elucidate the pathway of 5' SS selection by purified yeast U1 snRNP. We determined that U1 reversibly selects 5' SS in a sequence-dependent, two-step mechanism. A kinetic selection scheme enforces pairing at particular positions rather than overall duplex stability to achieve long-lived U1 binding. Our results provide a kinetic basis for how U1 may rapidly surveil nascent transcripts for 5' SS and preferentially accumulate at these sequences rather than on close cognates.